API OMR GLOBAL

Propofol Market

  • Home
  • »
  • Propofol Market

Propofol Market Size, Share & Industry Analysis, By Type (Active Pharmaceutical Ingredient, Finished Dosage), By Application (Anesthesia, Sedation, ICU Sedation), By Distribution Channel (Hospitals, Retail Pharmacies, Online Providers), Forecast 2025–2035

The Propofol market is expected to grow at a CAGR of 5.1% from 2025 to 2035, primarily driven by the increasing number of surgeries and medical procedures requiring general anesthesia, along with the growing use of sedation in intensive care units (ICUs). Propofol, a short-acting sedative-hypnotic agent, is widely used for the induction and maintenance of general anesthesia and for sedation in ICU settings. It is favored for its rapid onset and short duration of action, reducing recovery times in patients. The demand for propofol is also being spurred by the increasing use of minimally invasive surgeries, which require short-term anesthesia.

Geographically, the North American market remains the largest, supported by advanced healthcare infrastructure, high surgery rates, and the widespread use of propofol in both general and procedural anesthesia. Europe follows closely with a well-established patient base for surgeries and ICUs. The Asia-Pacific region is expected to experience the highest growth due to improvements in healthcare infrastructure, growing surgical volumes, and increasing adoption of sedation in ICU settings. In Latin America and the Middle East & Africa, market growth is driven by improving access to modern anesthetics and expanding hospital and clinic networks.

The Propofol market report focuses on high-purity formulations, regulatory compliance, and cost-effective production techniques are expected to gain significant market share. Furthermore, as patient safety and recovery times become more critical, the demand for safe, effective sedatives like propofol will continue to rise.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Propofol
  • Key End-Users & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Type
  • Active Pharmaceutical Ingredient
  • Finished Dosage
  • By Application
    • Anesthesia
    • Sedation
    • ICU Sedation
  • By Distribution Channel
    • Hospitals
    • Retail Pharmacies
  • Online Providers
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
  • Fresenius Kabi USA
  • SI Group
  • Dongkook Pharmaceutical Co., Ltd.
  • Harman Finochem Ltd.
  • Emcure Pharmaceuticals Ltd.
  • Manus Aktteva Biopharma LLP
  • Troikaa Pharmachem Pvt. Ltd.
  • Bachem AG
  • Guangzhou Tosun Pharmaceutical Ltd.
  • Anhui Medipharm Co., Ltd.
  • Guangzhou Sinolead Biotech Co., Ltd.
  • Zhangjiagang Free Trade Zone Megawide Chemical Technology Co., Ltd.
  • Beijing Mesochem Technology Co., Ltd.
  • Sinopharm Chemical Reagent Co., Ltd.
  • Shanghai Aladdin Bio-Chem Technology Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Hubei Jusheng Technology Co., Ltd.
  • Wuhan Hezhong Pharmaceutical Co., Ltd.
  • Anant Pharmaceuticals Pvt. Ltd.
  • BASF SE
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Propofol?
Propofol is a widely used intravenous anesthetic agent primarily utilized for the induction and maintenance of general anesthesia during surgical procedures. It is also used for sedation in intensive care units (ICUs). Propofol works by promoting the activity of GABA (gamma-aminobutyric acid), which has calming effects on the central nervous system, leading to sedative and anesthetic effects.
What is the market growth of Propofol?
The global Propofol market is expected to grow at a CAGR of 5.1% between 2025 and 2035. The growth is driven by the increasing number of surgeries and medical procedures worldwide, rising demand for short-acting anesthetic agents, and the continued expansion of intensive care units, particularly in developing economies.
What are the drivers of the Propofol Market?
Key drivers include the rise in elective surgeries, advancements in healthcare infrastructure, particularly in emerging markets, and the shift towards outpatient surgeries requiring short-term anesthesia.
Who are the key players operating in the Propofol Market?
Major players in the Propofol market include Fresenius Kabi, Baxter International Inc., Hospira (now part of Pfizer), Mylan, and Lunan Pharmaceutical Group.
Which region would exhibit the fastest growth in the Propofol Market?
Asia-Pacific is expected to exhibit the fastest growth in the Propofol market. This is driven by the increasing number of surgeries, improvements in healthcare facilities, rising demand for sedatives in intensive care units, and growing healthcare investments in countries such as China, India, and Japan.
$2500/- Single User License
$4000/- Multi User License
$5500/- Corporate License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.